Our invest­ment scope includes ther­a­peu­tics, diag­nos­tics and med­ical tech­nol­o­gy prod­ucts. We favor com­pa­nies that are poised to devel­op a strong com­pet­i­tive edge, based on pro­pri­etary tech­nol­o­gy and prod­ucts that address real med­ical needs. Management must be able to exe­cute a smart strat­e­gy, includ­ing a focused and cap­i­tal-effi­cient route to strate­gic part­ner­ships and, in time, an investors’ exit.

We invest in return for a sig­nif­i­cant equi­ty stake. We may com­mit up to approx­i­mate­ly € 3 mil­lion and usu­al­ly invest togeth­er with oth­er pro­fes­sion­al cap­i­tal providers, often as a (co-)lead investor.

If an invest­ment pro­pos­al does not meet all our require­ments but other­wise offers strong poten­tial, we invite man­age­ment to work with us to devel­op a fund­able pro­pos­al.